BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huynh MB, Ouidja MO, Chantepie S, Carpentier G, Maïza A, Zhang G, Vilares J, Raisman-Vozari R, Papy-Garcia D. Glycosaminoglycans from Alzheimer's disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau. PLoS One 2019;14:e0209573. [PMID: 30608949 DOI: 10.1371/journal.pone.0209573] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Marcisz M, Maszota-Zieleniak M, Samsonov SA. Repulsive Scaling Replica Exchange Molecular Dynamics in Modeling Protein-Glycosaminoglycan Complexes. Methods Mol Biol 2023;2619:153-67. [PMID: 36662469 DOI: 10.1007/978-1-0716-2946-8_12] [Reference Citation Analysis]
2 Zhu Y, Gandy L, Zhang F, Liu J, Wang C, Blair LJ, Linhardt RJ, Wang L. Heparan Sulfate Proteoglycans in Tauopathy. Biomolecules 2022;12. [PMID: 36551220 DOI: 10.3390/biom12121792] [Reference Citation Analysis]
3 Peng W, Kobeissy F, Mondello S, Barsa C, Mechref Y. MS-based glycomics: An analytical tool to assess nervous system diseases. Front Neurosci 2022;16. [DOI: 10.3389/fnins.2022.1000179] [Reference Citation Analysis]
4 Guillemain G, Lacapere J, Khemtemourian L. Targeting hIAPP fibrillation: A new paradigm to prevent β-cell death? Biochimica et Biophysica Acta (BBA) - Biomembranes 2022;1864:184002. [DOI: 10.1016/j.bbamem.2022.184002] [Reference Citation Analysis]
5 Pintér P, Alpár A. The Role of Extracellular Matrix in Human Neurodegenerative Diseases. IJMS 2022;23:11085. [DOI: 10.3390/ijms231911085] [Reference Citation Analysis]
6 Ramos-martínez IE, Ramos-martínez E, Segura-velázquez RÁ, Saavedra-montañez M, Cervantes-torres JB, Cerbón M, Papy-garcia D, Zenteno E, Sánchez-betancourt JI. Heparan Sulfate and Sialic Acid in Viral Attachment: Two Sides of the Same Coin? IJMS 2022;23:9842. [DOI: 10.3390/ijms23179842] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Marcisz M, Gaardløs M, Bojarski KK, Siebenmorgen T, Zacharias M, Samsonov SA. Explicit solvent repulsive scaling replica exchange molecular dynamics (RS-REMD) in molecular modeling of protein-glycosaminoglycan complexes. J Comput Chem 2022. [PMID: 35796487 DOI: 10.1002/jcc.26965] [Reference Citation Analysis]
8 Huynh MB, Rebergue N, Merrick H, Gomez-Henao W, Jospin E, Biard DSF, Papy-Garcia D. HS3ST2 expression induces the cell autonomous aggregation of tau. Sci Rep 2022;12:10850. [PMID: 35760982 DOI: 10.1038/s41598-022-13486-6] [Reference Citation Analysis]
9 Fawcett JW, Kwok JCF. Proteoglycan Sulphation in the Function of the Mature Central Nervous System. Front Integr Neurosci 2022;16:895493. [DOI: 10.3389/fnint.2022.895493] [Reference Citation Analysis]
10 Scarlett JM, Hu SJ, Alonge KM. The “Loss” of Perineuronal Nets in Alzheimer's Disease: Missing or Hiding in Plain Sight? Front Integr Neurosci 2022;16:896400. [DOI: 10.3389/fnint.2022.896400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tshilenge K, Aguirre CG, Bons J, Basisty N, Song S, Rose J, Lopez-ramirez A, Gerencser A, Naphade S, Loureiro A, Wehrfritz C, Holtz A, Mooney S, Schilling B, Ellerby LM. Proteomic Analysis of Huntington’s Disease Medium Spiny Neurons Identifies Alterations in Lipid Droplets.. [DOI: 10.1101/2022.05.11.491152] [Reference Citation Analysis]
12 Pereira PM, Papy-garcia D, Barritault D, Chiappini F, Jackisch R, Schimchowitsch S, Cassel J. Protective Effects of a synthetic glycosaminoglycan mimetic (OTR4132) in a rat immunotoxic lesion model of septohippocampal cholinergic degeneration. Glycoconj J. [DOI: 10.1007/s10719-022-10047-x] [Reference Citation Analysis]
13 Ennemoser M, Pum A, Kungl A. Disease-specific glycosaminoglycan patterns in the extracellular matrix of human lung and brain. Carbohydr Res 2021;511:108480. [PMID: 34837849 DOI: 10.1016/j.carres.2021.108480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Limorenko G, Lashuel HA. To target Tau pathologies, we must embrace and reconstruct their complexities. Neurobiol Dis 2021;161:105536. [PMID: 34718129 DOI: 10.1016/j.nbd.2021.105536] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
15 Snow AD, Cummings JA, Lake T. The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago. Front Aging Neurosci 2021;13:710683. [PMID: 34671250 DOI: 10.3389/fnagi.2021.710683] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
16 Logsdon AF, Francis KL, Richardson NE, Hu SJ, Faber CL, Phan BA, Nguyen V, Setthavongsack N, Banks WA, Woltjer RL, Keene CD, Latimer CS, Schwartz MW, Scarlett JM, Alonge KM. Decoding perineuronal net glycan sulfation patterns in the Alzheimer's disease brain. Alzheimers Dement 2021. [PMID: 34482642 DOI: 10.1002/alz.12451] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Freitas A, Aroso M, Rocha S, Ferreira R, Vitorino R, Gomez-Lazaro M. Bioinformatic analysis of the human brain extracellular matrix proteome in neurodegenerative disorders. Eur J Neurosci 2021;53:4016-33. [PMID: 34013613 DOI: 10.1111/ejn.15316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 De Risi M, Tufano M, Alvino FG, Ferraro MG, Torromino G, Gigante Y, Monfregola J, Marrocco E, Pulcrano S, Tunisi L, Lubrano C, Papy-Garcia D, Tuchman Y, Salleo A, Santoro F, Bellenchi GC, Cristino L, Ballabio A, Fraldi A, De Leonibus E. Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders. Nat Commun 2021;12:3495. [PMID: 34108486 DOI: 10.1038/s41467-021-23903-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
19 Azevedo T, Dimitri GM, Lió P, Gamazon ER. Multilayer modelling of the human transcriptome and biological mechanisms of complex diseases and traits. NPJ Syst Biol Appl 2021;7:24. [PMID: 34045472 DOI: 10.1038/s41540-021-00186-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Mah D, Zhao J, Liu X, Zhang F, Liu J, Wang L, Linhardt R, Wang C. The Sulfation Code of Tauopathies: Heparan Sulfate Proteoglycans in the Prion Like Spread of Tau Pathology. Front Mol Biosci 2021;8:671458. [PMID: 34095227 DOI: 10.3389/fmolb.2021.671458] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 Schwab N, Ju Y, Hazrati LN. Early onset senescence and cognitive impairment in a murine model of repeated mTBI. Acta Neuropathol Commun 2021;9:82. [PMID: 33964983 DOI: 10.1186/s40478-021-01190-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
22 Clark C, Dayon L, Masoodi M, Bowman GL, Popp J. An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease. Alzheimers Res Ther 2021;13:71. [PMID: 33794997 DOI: 10.1186/s13195-021-00814-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
23 Pérez-López N, Martín C, García B, Solís-Hernández MP, Rodríguez D, Alcalde I, Merayo J, Fernández-Vega I, Quirós LM. Alterations in the Expression of the Genes Responsible for the Synthesis of Heparan Sulfate in Brains With Alzheimer Disease. J Neuropathol Exp Neurol 2021;80:446-56. [PMID: 33779723 DOI: 10.1093/jnen/nlab028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Bu C, Jin L. NMR Characterization of the Interactions Between Glycosaminoglycans and Proteins. Front Mol Biosci 2021;8:646808. [PMID: 33796549 DOI: 10.3389/fmolb.2021.646808] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
25 Shi D, Sheng A, Chi L. Glycosaminoglycan-Protein Interactions and Their Roles in Human Disease. Front Mol Biosci 2021;8:639666. [PMID: 33768117 DOI: 10.3389/fmolb.2021.639666] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 16.5] [Reference Citation Analysis]
26 Jin W, Zhang F, Linhardt RJ. Glycosaminoglycans in Neurodegenerative Diseases. Adv Exp Med Biol 2021;1325:189-204. [PMID: 34495536 DOI: 10.1007/978-3-030-70115-4_9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
27 Okolicsanyi RK, Oikari LE, Yu C, Haupt LM. Proteoglycans, Neurogenesis and Stem Cell Differentiation. Proteoglycans in Stem Cells 2021. [DOI: 10.1007/978-3-030-73453-4_6] [Reference Citation Analysis]
28 Nam G, Lin Y, Lim MH, Lee Y. Key Physicochemical and Biological Factors of the Phase Behavior of Tau. Chem 2020;6:2924-63. [DOI: 10.1016/j.chempr.2020.09.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
29 Alghamdi N, Chang W, Dang P, Lu X, Wan C, Gampala S, Huang Z, Wang J, Ma Q, Zang Y, Fishel M, Cao S, Zhang C. A graph neural network model to estimate cell-wise metabolic flux using single cell RNA-seq data.. [DOI: 10.1101/2020.09.23.310656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
30 Wang Y, Nakajima T, Diao P, Yamada Y, Nakamura K, Nakayama J, Tanaka N, Aoyama T, Kamijo Y. Polyunsaturated fatty acid deficiency affects sulfatides and other sulfated glycans in lysosomes through autophagy-mediated degradation. FASEB J 2020;34:9594-614. [PMID: 32501606 DOI: 10.1096/fj.202000030RR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Castle MJ, Baltanás FC, Kovacs I, Nagahara AH, Barba D, Tuszynski MH. Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery. Hum Gene Ther 2020;31:415-22. [PMID: 32126838 DOI: 10.1089/hum.2019.367] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
32 Brunello CA, Merezhko M, Uronen RL, Huttunen HJ. Mechanisms of secretion and spreading of pathological tau protein. Cell Mol Life Sci 2020;77:1721-44. [PMID: 31667556 DOI: 10.1007/s00018-019-03349-1] [Cited by in Crossref: 102] [Cited by in F6Publishing: 83] [Article Influence: 25.5] [Reference Citation Analysis]